| Recruiting | 4 | 6000 | US | SGLT2 inhibitor, GLP-1 receptor agonist | Brigham and Women's Hospital, Patient-Centered Outcomes Research Institute | Type2Diabetes, ASCVD | 03/29 | 03/29 | | |
NCT04042467: Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention |
|
|
| Completed | N/A | 900 | US | Greenlight Plus, Greenlight | Vanderbilt University Medical Center, Patient-Centered Outcomes Research Institute, Duke University, University of North Carolina, Chapel Hill, Stanford University, NYU Langone Health, University of Miami, Johns Hopkins University | Behavior, Health, Child Obesity | 01/24 | 01/24 | | |
